Janux Therapeutics, Inc.JANXEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Janux Therapeutics, Inc. is a clinical-stage biotechnology company specializing in developing novel T cell engager immunotherapies for treating solid tumors and hematological malignancies. It primarily operates in the U.S. biopharmaceutical market, focusing on the oncology segment to address unmet medical needs for patients with hard-to-treat cancers.